Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PETMED EXPRESS, INC.

(PETS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PetMed Express : Hires Matt Hulett as CEO

08/31/2021 | 09:35am EST


ę MT Newswires 2021
All news about PETMED EXPRESS, INC.
11/18PetMed Express Shares Lower After Morgan Stanley Begins Coverage at Underweight
MT
11/18Morgan Stanley Initiates PetMed Express at Underweight With $25 Price Target
MT
11/05PETMED EXPRESS, INC. : Ex-dividend day for
FA
11/02PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
10/27QUARTER ENDED SEPTEMBER 30, 2021 CON : 30 P.M. ET - Form 8-K
PU
10/26AFTER HOURS WATCH LIST SCORECARD : Cdmo, pets, clar
MT
10/26PETMED EXPRESS ANNOUNCES ITS SECOND QUARTER FINANCIAL RESULTS AND ITS QUARTELY DIVIDEND..
PU
10/25MT NEWSWIRES AFTER HOURS WATCH LIST : Cdmo, pets, clar
MT
10/25PETMED EXPRESS : Fiscal Q2 Profit Slides as Sales Drop Almost 11%; Keeps Quarterly Dividen..
MT
10/25PETMED : Fiscal Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2022 285 M - -
Net income 2022 24,0 M - -
Net cash 2022 115 M - -
P/E ratio 2022 23,1x
Yield 2022 4,50%
Capitalization 548 M 548 M -
EV / Sales 2022 1,52x
EV / Sales 2023 1,43x
Nbr of Employees 219
Free-Float 93,4%
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Last Close Price 27,10 $
Average target price 27,67 $
Spread / Average Target 2,09%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Ronald J. Korn Independent Director
Frank J. Formica Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-16.63%548
RAIA DROGASIL S.A.-11.22%6 511
AIN HOLDINGS INC.-2.83%1 885
RITE AID CORPORATION-27.23%649
QOL HOLDINGS CO., LTD.20.00%431
HLS THERAPEUTICS INC.-15.78%384